IMARC Group’s report titled “Allergy Treatment Market Report by Type (Eye Allergy, Skin Allergy, Food Allergy, Asthma, Rhinitis, and Others), Treatment (Anti-Allergy Drugs, Immunotherapy), Dosage Form (Oral, Inhalers, Intranasal, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Retailers, and Others), and Region 2024-2032. offers a comprehensive analysis of the industry, which comprises insights on the global allergy treatment market share. The global market size reached US$ 22.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 35.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.
Factors Affecting the Growth of the Allergy Treatment Industry:
● Growing Prevalence of Allergic Disorders:
Allergic disorders like rhinitis, asthma, and food allergies are rising globally. This increase is pushing market growth. Factors such as pollution, climate change, and urbanization are making allergies more common, especially in cities. Moreover, changes in diet and exposure to allergens are worsening allergic reactions. As more people seek treatment, the demand for effective allergy medicines, including antihistamines, decongestants, and immunotherapy, is growing. This trend is especially strong in developed areas with higher awareness and diagnosis rates.
● Advancements in Allergy Treatment and Diagnostic Technologies:
New technology is boosting the allergy market. Advanced tests now identify allergens more accurately. This leads to better, targeted treatments. Moreover, new treatments like biologics and sublingual immunotherapy are emerging. These options improve patient care, especially for those unresponsive to standard therapies.
● Increasing Awareness and Patient Education:
Awareness of allergies and the need for early treatment is boosting market growth. Public campaigns, healthcare education, and online information are key. They help people understand allergy symptoms, triggers, and treatments. This prompts more to seek help and follow treatments, improving management. Moreover, healthcare providers are now focusing on personalized plans and boosting awareness to enhance compliance and outcomes.
Grab a sample PDF of this report: https://www.imarcgroup.com/allergy-treatment-market/requestsample
Leading Companies Operating in the Global Allergy Treatment Industry:
- AbbVie Inc.
- ALK-Abelló A/S
- Allergopharma (Dermapharm AG)
- Allergy Therapeutics
- Almirall S.A
- AstraZeneca plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- HAL Allergy Group (Droege International Group)
- Leti Pharma
- Nicox S.A.
- Sanofi S.A.
- Stallergenes Greer.
Allergy Treatment Market Report Segmentation:
By Type:
- Eye Allergy
- Skin Allergy
- Food Allergy
- Asthma
- Rhinitis
- Others
Rhinitis exhibits a clear dominance in the market due to its high prevalence and the substantial demand for effective symptom management among affected individuals.
By Treatment:
- Anti-Allergy Drugs
- Immunotherapy
Anti-allergy drugs represent the largest segment because they provide quick and accessible relief, making them the first-line treatment for most allergic conditions.
By Dosage From:
- Oral
- Inhalers
- Intranasal
- Others
Based on the dosage form, the market has been categorized into oral, inhalers, intranasal, and others.
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Retailers
- Others
On the basis of the distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, online retailers, and others.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America dominates the market owing to its advanced healthcare infrastructure, high awareness levels, and significant investments in allergy research and treatment.
Global Allergy Treatment Market Trends:
The rise in popularity of subcutaneous and sublingual immunotherapy is boosting the market. Immunotherapy is favored for its long-term allergy management. It alters the immune system's response to allergens, unlike traditional treatments that only relieve symptoms. This approach targets the root cause, offering lasting relief after treatment ends. Ongoing clinical studies prove its safety and effectiveness. Thus, more doctors are now recommending it. This trend is strong in developed regions, where there's a shift towards personalized and preventive care. New formats, like tablets and drops, make immunotherapy easier and more accessible.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145
